Home
About
Overview
Sharing Data
ORCID
Help
History (39)
Impact of comorbidities on atrial fibrillation and sudden cardiac death in hypertrophic cardiomyopathy.
Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.
Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives.
Identification of Fabry Disease in a Tertiary Referral Cohort of Patients with Hypertrophic Cardiomyopathy.
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
See All 39 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten?
Maron MS, Rowin EJ, Maron BJ. Is surgical myectomy challenged by emergence of novel drug therapy with mavacamten? Asian Cardiovasc Thorac Ann. 2022 Jan; 30(1):11-18.
View in:
PubMed
subject areas
Benzylamines
Cardiomyopathy, Hypertrophic
Humans
Treatment Outcome
Uracil
authors with profiles
Martin S Maron MD, MSPH
Barry J Maron MD
Ethan Rowin MD, MBA